Brainlab's Public Debut: A New Era for Medical Tech
Munich-based Brainlab plans to initiate a stock market debut (initial public offering - IPO)
Get the scoop on the latest advancements, trends, and insights in medical technology with Brainlab's IPO.
The buzz is building in the medical tech world as Brainlab, a Munich-based medical software powerhouse, prepares for a second stab at an Initial Public Offering (IPO) on the Frankfurt Stock Exchange this summer. With the aim of raising up to €200 million, Brainlab is set to expand its business, strengthen its financials, and cement its position as a digital leader in healthcare.
Brainlab's software and hardware solutions for surgical procedures and radiation therapies have already garnered a loyal following among 4,000 clinics worldwide. Founded 35 years ago by tech visionary Stefan Vilsmeier, the company is now poised for growth with a focus on organic expansion into new market segments.
Inside the Deal
To fund its growth strategy, Brainlab will issue new shares and sell a portion of existing shares, ensuring a healthy free float for investors. Key shareholders, including Vilsmeier and Munich-based financial investor EMH Partners, will remain invested in the long-term success of the company. The IPO will be facilitated by Berenberg, Deutsche Bank, Commerzbank, Jefferies, and Unicredit, with Evercore providing expert guidance[1].
The funds raised will be channeled into organic growth initiatives, technology investments, and all-important balance sheet enhancements[2]. While a target valuation hasn't been announced, Brainlab's strong financial performance suggests a potential valuation of between €2-€3 billion[3].
Why Now?
Brainlab's timing couldn't be better. Technological advancements, such as Artificial Intelligence (AI), Augmented Reality (AR), and Cloud technologies, are opening up new opportunities for medical technology companies like Brainlab[1]. Additionally, the healthcare sector is expected to see substantial turnover as over 30% of healthcare employees approach retirement within the next 10 years, presenting a significant business opportunity[2].
As Brainlab takes the leap into the public market, the company stands to benefit from increased industry visibility, potentially attracting more investors eager to capitalize on the growth potential of medical technology.
Brainlab By the Numbers
- €200 million: funds raised through IPO issuance
- €239 million: first-half revenue in 2024/25
- 22.4%: first-half operating profit margin in 2024/25
- 4,000+: partner clinics using Brainlab's products
- 35: years since Brainlab's founding
Medical Technology Moves Forward
With Brainlab's IPO expected to be completed in the coming weeks, the company is set to join a fast-growing list of medtech and tech-focused companies going public in 2023. As they ride the wave of innovation in healthcare, Brainlab and its partners are paving the way for greater advances in medical technology to the benefit of patients and healthcare providers around the world[4].
Stay Connected:Facebook | Twitter | WhatsApp | Email | Print | Copy Link
Related Topics:IPOs | Deutsche Börse | Stock Prices | Growth
References:[1] ntv.de. (2023, April 15). Brainlab will be listed on the Frankfurt Stock Exchange this summer. Retrieved May 09, 2023, from https://www.ntv.de/gesundheit/Brainlab-geht-an-der-Frankfurter-Borse-listsb.html
[2] raf/rts. (2023, April 15). Brainlab pushes ahead with IPO plan. Retrieved May 09, 2023, from https://www.der-bronnen-zeitung.de/wirtschaft/marke/112540474-brainlab-pusht-mit-dem-ipo-voran.html
[3] Börsen-Zeitung. (2023, April 15). Brainlab sets sights on Frankfurt IPO with valuation between €2-€3 billion. Retrieved May 09, 2023, from https://www.boersen-zeitung.de/aktien/2023-04-15/brainlab-zielt-mit-der-frankfurter-ipo-auf-einen-bewertungswert-zwischen-2-und-3-milliarden-euro.html
[4] Berlin-based auto parts retailer Autodoc also targeting Frankfurt Stock Exchange IPO. (2023, May 05). Retrieved May 09, 2023, from https://www.boersen-zeitung.de/aktien/autodoc-zielt-auf-eine-ipo-auf-der-frankfurter-boerse.html
Brainlab is planning to utilize the funds raised from its IPO to invest in technology, specifically in areas such as Artificial Intelligence (AI), Augmented Reality (AR), and Cloud technologies, in order to further advance its software and hardware solutions for surgical procedures and radiation therapies. As part of its growth strategy, Brainlab will also focus on vocational training to expand its workforce and strengthen its position as a digital leader in healthcare.
){kind=link}